Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60
Abstract
The envelope glycoprotein of human immunodeficiency virus (HIV) initiates infection by mediating fusion of the viral envelope with the cell membrane. Fusion activity requires proteolytic cleavage of the gp160 protein into gp120 and gp41 at a site containing several arginine and lysine residues. Activation at basic cleavage sites is observed with many membrane proteins of cellular and viral origin. We have recently found that the enzyme activating the haemagglutinin of fowl plague virus (FPV), an avian influenza virus, is furin. Furin, a subtilisin-like eukaryotic endoprotease, has a substrate specificity for the consensus amino-acid sequence Arg-X-Lys/Arg-Arg at the cleavage site. We show here that the glycoprotein of HIV-1, which has the same protease recognition motif as the FPV haemagglutinin, is also activated by furin.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In HIV-1, the Env glycoproteins precursor, gp160, is cleaved in the Golgi by cellular furin or furin-like PRs into a mature surface glycoprotein gp120 and the transmembrane glycoprotein gp41.
“In case of HIV-1, the Env glycoproteins precursor, gp160, is cleaved in the Golgi by cellular furin or furin-like PRs into: (i) a mature surface glycoprotein gp120 and (ii) the transmembrane glycoprotein gp41”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Hallenberger et al. 1992
Cites
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,539 · see citing works
Human Retroviruses and Aids - 1999
KUIKEN, C. L., & Foley, B. T. (1999) · doi:10.2172/1186019 · Cited by 952 · see citing works
Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque Assay
Harada, S., Koyanagi, Y., & Yamamoto, N. (1985) · Science · doi:10.1126/science.2992081 · Cited by 857 · see citing works
Stieneke-Gröber, A., Vey, M., Angliker, H., Shaw, E., Thomas, G., Roberts, C. R., Klenk, H., & Garten, W. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05305.x · Cited by 643 · see citing works
Self-citationEndoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
McCune, J. M., Rabin, L. B., Feinberg, M. B., Lieberman, M., Kosek, J. C., Reyes, G. R., & Weissman, I. L. (1988) · Cell · doi:10.1016/0092-8674(88)90487-4 · Cited by 610 · see citing works
Hosaka, M., Nagahama, M., Kim, W. S., Watanabe, T., Hatsuzawa, K., Ikemizu, J., Murakami, K., & Nakayama, K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98867-8 · Cited by 591 · see citing works
Willey, R. L., Bonifacino, J. S., Potts, B. J., Martin, M. A., & Klausner, R. D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9580 · Cited by 428 · see citing works
Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo.
Bresnahan, P. A., Leduc, R., Thomas, L., Thorner, J. W., Gibson, H. L., Brake, A. J., Barr, P. J., & Thomas, G. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.111.6.2851 · Cited by 383 · see citing works
Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
Earl, P. L., Doms, R. W., & Moss, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.648 · Cited by 365 · see citing works
Wise, R. J., Barr, P. J., WONG, P. A., Kiefer, M. C., Brake, A. J., & Kaufman, R. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9378 · Cited by 293 · see citing works
Human retroviruses and AIDS 1994
Lab., N. (. S. L. A. N., Myers, G., Korber, B., Wain–Hobson, S., Jeang, K., Henderson, L., & Pavlakis, G. N. (1995) · doi:10.2172/10116202 · Cited by 273 · see citing works
van den Ouwel, A. M. W., van Duijnhoven, H. L. P., Keizer, G. D., Dorssers, L. C. J., & de Ven, W. J. M. V. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.3.664 · Cited by 203 · see citing works
Stein, B. S., & Engleman, E. G. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39849-7 · Cited by 189 · see citing works
Prince, A. M., Horowitz, B., Baker, L., Shulman, R., Ralph, H., Valinsky, J. E., Cundell, A., Brotman, B., Boehle, W., & Rey, F. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6944 · Cited by 161 · see citing works
Wilk, T., Pfeiffer, T., & Bosch, V. (1992) · Virology · doi:10.1016/0042-6822(92)90692-i · Cited by 155 · see citing works
Self-citationBosch, V., & Pawlita, M. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2337-2344.1990 · Cited by 128 · see citing works
Self-citationMergener, K., Fäcke, M., Welker, R., Brinkmann, V., Gelderblom, H. R., & Kr√§usslich, H. G. (1992) · Virology · doi:10.1016/0042-6822(92)90058-w · Cited by 125 · see citing works
Dewar, R. L., Vasudevachari, M. B., Natarajan, V., & Salzman, N. P. (1989) · Journal of Virology · doi:10.1128/jvi.63.6.2452-2456.1989 · Cited by 100 · see citing works
Willey, R. L., Klimkait, T., Frucht, D. M., Bonifacinot, J. S., & Martin, M. A. (1991) · Virology · doi:10.1016/0042-6822(91)90848-6 · Cited by 75 · see citing works
Owens, R. J., & Compans, R. W. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.978-982.1989 · Cited by 72 · see citing works
Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage
Guo, H.-G., Veronese, F. D. M., Tschachler, E., Pal, R., Kalyanaraman, V. S., Gallo, R. C., & Reitz, M. S. (1990) · Virology · doi:10.1016/0042-6822(90)90070-8 · Cited by 72 · see citing works
Garten, W., Stieneke-Gröber, A., Shaw, E. N., Wikström, P., & Klenk, H. (1989) · Virology · doi:10.1016/0042-6822(89)90103-7 · Cited by 60 · see citing works
Self-citationWilk, T., Mierswa, H., Kräusslich, H.-G., Dunn, J. J., & Bosch, V. (1992) · Virus Genes · doi:10.1007/bf01702562 · Cited by 10 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Chan, J. F., Lau, S. K. P., To, K. K., Cheng, V. C., Woo, P. C. Y., & Yuen, K. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-14 · Cited by 876 · see citing works
The biology and therapeutic targeting of the proprotein convertases
Seidah, N. G., & Prat, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3699 · Cited by 819 · see citing works
Nakayama, K. (1997) · Biochemical Journal · doi:10.1042/bj3270625 · Cited by 788 · see citing works
Seidah, N. G., & Chrétien, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01909-5 · Cited by 760 · see citing works
Furin-dependent intracellular activation of the human stromelysin-3 zymogen
Pei, D., & Weiss, S. J. (1995) · Nature · doi:10.1038/375244a0 · Cited by 629 · see citing works
Proteolytic activation of tick-borne encephalitis virus by furin
Stadler, K., Allison, S. L., Schalich, J., & Heinz, F. X. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8475-8481.1997 · Cited by 561 · see citing works
Binley, J. Μ., Sanders, R. W., Clas, B., Schülke, N., Master, A., Guo, Y., Kajumo, F., Anselma, D. J., Maddon, P. J., Olson, W. C., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.627-643.2000 · Cited by 533 · see citing works
Molloy, S. S., Thomas, L., VanSlyke, J. K., Stenberg, P. E., & Thomas, G. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06231.x · Cited by 487 · see citing works
Exploitation of glycosylation in enveloped virus pathobiology
Watanabe, Y., Bowden, T. A., Wilson, I. A., & Crispin, M. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.05.012 · Cited by 485 · see citing works
HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation
Checkley, M. A., Luttge, B. G., & Freed, E. O. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.042 · Cited by 477 · see citing works
Host cell proteases controlling virus pathogenicity
Klenk, H., & Garten, W. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90123-6 · Cited by 466 · see citing works
Self-citationProcessing of Transforming Growth Factor β1 Precursor by Human Furin Convertase
Dubois, C. M., Laprise, M., Blanchette, F., Gentry, L. E., & Leduc, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10618 · Cited by 405 · see citing works
Seidah, N. G., Chrétien, M., & Day, R. W. (1994) · Biochimie · doi:10.1016/0300-9084(94)90147-3 · Cited by 396 · see citing works
Overexpression of integral membrane proteins for structural studies
Grisshammer, R., & Tate, C. G. (1995) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500003504 · Cited by 388 · see citing works
Structural basis for membrane fusion by enveloped viruses
Weissenhorn, W., Dessen, A., Calder, L. J., Harrison, S. C., Skehel, J. J., & Wiley, D. C. (1999) · Molecular Membrane Biology · doi:10.1080/096876899294706 · Cited by 373 · see citing works
Henrich, S., Cameron, A., Bourenkov, G. P., Kiefersauer, R. A., Huber, R., Lindberg, I., Bode, W., & Than, M. E. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb941 · Cited by 343 · see citing works
Regulation of Membrane Type-1 Matrix Metalloproteinase Activation by Proprotein Convertases
Yana, I., & Weiss, S. J. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.7.2387 · Cited by 322 · see citing works
Tortorec, A. L., & Neil, S. J. D. (2009) · Journal of Virology · doi:10.1128/jvi.01515-09 · Cited by 282 · see citing works
Ebolavirus Glycoprotein Structure and Mechanism of Entry
Lee, J. E., & Saphire, E. O. (2009) · Future Virology · doi:10.2217/fvl.09.56 · Cited by 281 · see citing works
The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection
Freed, E. O., & Martin, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23883 · Cited by 274 · see citing works
Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Peptide
Münch, J., Ständker, L., Adermann, K., Schulz, A., Schindler, M., Chinnadurai, R., Pöhlmann, S., Chaipan, C., Biet, T., Peters, T., et al. (2007) · Cell · doi:10.1016/j.cell.2007.02.042 · Cited by 261 · see citing works
Montero, M., van Houten, N. E., Wang, X., & Scott, J. K. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00020-07 · Cited by 251 · see citing works
McNeely, T. B., Shugars, D. C., Rosendahl, M. S., Tucker, C., Eisenberg, S. P., & Wahl, S. M. (1997) · Blood · doi:10.1182/blood.v90.3.1141 · Cited by 253 · see citing works
Evidence that Furin Is an Authentic Transforming Growth Factor-β1-Converting Enzyme
Dubois, C. M., Blanchette, F., Laprise, M., Leduc, R., Grondin, F., & Seidah, N. G. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63970-3 · Cited by 248 · see citing works
Schäfer, W., Stroh, A., Berghöfer, S., Seiler, J., Vey, M., Kruse, M., Kern, H. F., Klenk, H., & Garten, W. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07240.x · Cited by 245 · see citing works
Self-citationSeidah, N. G., Hamelin, J., Mamarbachi, M., Dong, W., Tardos, H., Mbikay, M., Chrétien, M., & Day, R. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3388 · Cited by 245 · see citing works
López‐Fraga, M., Fernández, R., Albar, J. P., & Hahne, M. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve198 · Cited by 222 · see citing works
Horimoto, T., Nakayama, K., Smeekens, S. P., & Kawaoka, Y. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.6074-6078.1994 · Cited by 220 · see citing works
HIV entry and envelope glycoprotein-mediated fusion
Blumenthal, R., Durell, S., & Viard, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.406272 · Cited by 212 · see citing works
Molecular Mechanisms of HIV Entry
Wilen, C. B., Tilton, J. C., & Doms, R. W. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0980-9_10 · Cited by 215 · see citing works
Böttcher‐Friebertshäuser, E., Freuer, C., Sielaff, F., Schmidt, S., Eickmann, M., Uhlendorff, J., Steinmetzer, T., Klenk, H., & Garten, W. (2010) · Journal of Virology · doi:10.1128/jvi.00140-10 · Cited by 212 · see citing works
Self-citationInhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant.
Anderson, E. D., Thomas, L., Hayflick, J. S., & Thomas, G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74548-7 · Cited by 212 · see citing works
Kam, Y., Lum, F., Teo, T., Lee, W. W. L., Simarmata, D., Harjanto, S., Chua, C. L., Chan, Y. F., Wee, J. S., Chow, A. L., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200213 · Cited by 209 · see citing works
Curbing activation: proprotein convertases in homeostasis and pathology
Taylor, N. A., de Ven, W. J. M. V., & Creemers, J. W. M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0831rev · Cited by 204 · see citing works
Precursor Processing by Kex2/Furin Proteases
Rockwell, N. C., Krysan, D. J., Komiyama, T., & Fuller, R. S. (2002) · Chemical Reviews · doi:10.1021/cr010168i · Cited by 201 · see citing works
Retrieval of TGN proteins from the cell surface requires endosomal acidification.
Chapman, R. E., & Munro, S. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06514.x · Cited by 186 · see citing works
Subtilase-like pro-protein convertases: from molecular specificity to therapeutic applications
Bergeron, F., Leduc, R., & Day, R. W. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0240001 · Cited by 184 · see citing works
Nieva, J. L., Nir, S., Muga, A., Goñi, F. M., & Wilschut, J. (1994) · Biochemistry · doi:10.1021/bi00177a009 · Cited by 184 · see citing works
Proprotein Convertases in Health and Disease
Artenstein, A. W., & Opal, S. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1106700 · Cited by 183 · see citing works
Jones, B. G., Thomas, L., Molloy, S. S., Thulin, C. D., Fry, M. D., Walsh, K. A., & Thomas, G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00275.x · Cited by 183 · see citing works
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity
Essalmani, R., Jain, J., Susan‐Resiga, D., Andréo, U., Evagelidis, A., Derbali, R. M., Huynh, D. N., Dallaire, F., Laporte, M., Delpal, A., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00128-22 · Cited by 183 · see citing works
Garten, W., Hallenberger, S., Ortmann, D., Schäfer, W., Vey, M., Angliker, H., Shaw, E., & Klenk, H. (1994) · Biochimie · doi:10.1016/0300-9084(94)90149-x · Cited by 167 · see citing works
Self-citationIntracellular Maturation of the Mouse Metalloprotease Disintegrin MDC15
Lum, L., Reid, M. S., & Blobel, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26236 · Cited by 166 · see citing works
Bour, S. P., Geleziunas, R., & Wainberg, M. A. (1995) · Microbiological Reviews · doi:10.1128/mmbr.59.1.63-93.1995 · Cited by 167 · see citing works
Novel insights into proteolytic cleavage of influenza virus hemagglutinin
Bertram, S., Glowacka, I., Steffen, I., Krämer-Kühl, A., & Pöhlmann, S. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.657 · Cited by 163 · see citing works
Vey, M., Schäfer, W., Berghöfer, S., Klenk, H., & Garten, W. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.6.1829 · Cited by 157 · see citing works
Self-citationLodge, R., Göttlinger, H., Gabuzda, D., Cohen, É., & Lemay, G. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4857-4861.1994 · Cited by 172 · see citing works
Maturation of HIV envelope glycoprotein precursors by cellular endoproteases
Moulard, M., & Decroly, É. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(00)00014-9 · Cited by 152 · see citing works
Pancera, M., & Wyatt, R. T. (2004) · Virology · doi:10.1016/j.virol.2004.10.042 · Cited by 151 · see citing works
Crimean-Congo Hemorrhagic Fever Virus Glycoprotein Proteolytic Processing by Subtilase SKI-1
Vincent, M. J., Sanchez, A. J., Erickson, B. R., Basak, A., Chrétien, M., Seidah, N. G., & Nichol, S. T. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8640-8649.2003 · Cited by 151 · see citing works
Rovida, E., Paccagnini, A., Rosso, M. D., Peschon, J. J., & Sbarba, P. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1583 · Cited by 149 · see citing works
The Pore-forming Toxin Proaerolysin Is Activated by Furin
Abrami, L., Fivaz, M. L., Decroly, É., Seidah, N. G., Jean, F., Thomas, G., Leppla, S. H., Buckley, J. T., & van der Goot, F. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32656 · Cited by 149 · see citing works
Bures, R., Gaitan, A., Zhu, T., Graziosi, C., McGrath, K. M., Tartaglia, J., Caudrelier, P., Habib, R. E., Klein, M. C. A., Lazzarin, A., et al. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/088922200750054756 · Cited by 147 · see citing works
Bravo, D. A., Gleason, J., Sanchez, R. I., Roth, R. A., & Fuller, R. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47322-x · Cited by 145 · see citing works
Wong, A., Sandesara, R. G., Mulherkar, N., Whelan, S. P. J., & Chandran, K. (2009) · Journal of Virology · doi:10.1128/jvi.01832-09 · Cited by 143 · see citing works
The neuroendocrine polypeptide 7B2 is an endogenous inhibitor of prohormone convertase PC2.
Martens, G. J. M., Braks, J. A. M., Eib, D. W., Zhou, Y., & Lindberg, I. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.5784 · Cited by 143 · see citing works
Pei, D., Kang, T., & Qi, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006493200 · Cited by 142 · see citing works
Liu, G., Thomas, L., Warren, R. A., Enns, C. A., Cunningham, C. C., Hartwig, J. H., & Thomas, G. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.7.1719 · Cited by 139 · see citing works
Inhibition of Chikungunya Virus Infection in Cultured Human Muscle Cells by Furin Inhibitors
Ozden, S., Lucas‐Hourani, M., Ceccaldi, P., Basak, A., Valentine, M., Benjannet, S., Hamelin, J., Jacob, Y., Mamchaoui, K., Mouly, V., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802444200 · Cited by 138 · see citing works
Proteolytic processing of the hepatocyte growth factor/scatter factor receptor by furin
Komada, M., Hatsuzawa, K., Shibamoto, S., Ito, F., Nakayama, K., & Kitamura, N. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80958-w · Cited by 135 · see citing works
Berglund, P., QUESADA-ROLANDER, M., Putkonen, P., Biberfeld, G., Thorstensson, R., & Liljeström, P. (1997) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1997.13.1487 · Cited by 135 · see citing works
Decroly, É., Vandenbranden, M., Ruysschaert, J., Cogniaux, J., Jacob, G. S., Howard, S. C., Marshall, G. R., Kompelli, A., Basak, A., & Jean, F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32707-2 · Cited by 132 · see citing works
A Novel Baculovirus Envelope Fusion Protein with a Proprotein Convertase Cleavage Site
IJkel, W. F. J., Westenberg, M., Goldbach, R. W., Blissard, G. W., Vlak, J. M., & Zuidema, D. (2000) · Virology · doi:10.1006/viro.2000.0483 · Cited by 131 · see citing works
Entry inhibitors and their use in the treatment of HIV-1 infection
Haqqani, A. A., & Tilton, J. C. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.03.017 · Cited by 129 · see citing works
Chiron, M. F., Fryling, C. M., & FitzGerald, D. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32431-6 · Cited by 129 · see citing works
The Hemagglutinin: A Determinant of Pathogenicity
Böttcher‐Friebertshäuser, E., Garten, W., Matrosovich, M. N., & Klenk, H. D. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_384 · Cited by 122 · see citing works
Self-citationThe Prosegments of Furin and PC7 as Potent Inhibitors of Proprotein Convertases
Zhong, M., Munzer, J. S., Basak, A., Benjannet, S., Mowla, S. J., Decroly, É., Chrétien, M., & Seidah, N. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.33913 · Cited by 128 · see citing works
Modulation of furin-mediated proprotein processing activity by site-directed mutagenesis.
Creemers, J. W. M., Siezen, R. J., Roebroek, A., Ayoubi, T., Huylebroeck, D., & de Ven, W. J. V. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80616-4 · Cited by 128 · see citing works
Willnow, T. E., Moehring, J. M., Inocencio, N. M., Moehring, T. J., & Herz, J. (1996) · Biochemical Journal · doi:10.1042/bj3130071 · Cited by 127 · see citing works
Alterations of pr-M Cleavage and Virus Export in pr-M Junction Chimeric Dengue Viruses
Keelapang, P., Sriburi, R., Supasa, S., Panyadee, N., Songjaeng, A., Jairungsri, A., Puttikhunt, C., Kasinrerk, W., Malasit, P., & Sittisombut, N. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2367-2381.2004 · Cited by 127 · see citing works
The Tale of the Long Tail: the Cytoplasmic Domain of HIV-1 gp41
Postler, T. S., & Desrosiers, R. C. (2012) · Journal of Virology · doi:10.1128/jvi.02053-12 · Cited by 122 · see citing works
Wang, P., Tortorella, M. D., England, K. A., Malfait, A., Thomas, G., Arner, E. C., & Pei, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312797200 · Cited by 122 · see citing works
Becker, G. L., Lu, Y., Hardes, K., Strehlow, B., Levesque, C., Lindberg, I., Sandvig, K., Bakowsky, U., Day, R. W., Garten, W., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.332643 · Cited by 118 · see citing works
Self-citationBasak, A., Cooper, S. F., Roberge, A. G., Banik, U. K., Chrétien, M., & Seidah, N. G. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380107 · Cited by 118 · see citing works
Inhibition of Furin by Polyarginine-containing Peptides
Kacprzak, M. M., Peinado, J. R., Than, M. E., Appel, J. R., Henrich, S., Lipkind, G. M., Houghten, R. A., Bode, W., & Lindberg, I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400484200 · Cited by 118 · see citing works
Post-translational Processing of the Insulin-like Growth Factor-2 Precursor
Duguay, S. J., Jin, Y., Stein, J. M., Duguay, A. N., Gardner, P., & Steiner, D. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18443 · Cited by 118 · see citing works
Becker, G. L., Sielaff, F., Than, M. E., Lindberg, I., Routhier, S., Day, R. W., Lu, Y., Garten, W., & Steinmetzer, T. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9012455 · Cited by 117 · see citing works
Self-citationProteolytic activation of bacterial toxins: role of bacterial and host cell proteases
Gordon, V. M., & Leppla, S. H. (1994) · Infection and Immunity · doi:10.1128/iai.62.2.333-340.1994 · Cited by 116 · see citing works
Stawowy, P., Meýborg, H., Stibenz, D., Stawowy, N. B. P., Roser, M., Thanabalasingam, U., Veinot, J. P., Chrétien, M., Seidah, N. G., Fleck, E., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.502617 · Cited by 115 · see citing works
Stawowy, P., Margeta, C., Kallisch, H., Seidah, N. G., Chrétien, M., Fleck, E., & Graf, K. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.03.010 · Cited by 113 · see citing works
Enfuvirtide, the first fusion inhibitor to treat HIV infection.
Poveda, E., Briz, V., & Soriano, V. (2005) · PubMed · Cited by 112 · see citing works
Decroly, É., Wouters, S., Bello, C. D., Lazure, C., Ruysschaert, J., & Seidah, N. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30442 · Cited by 111 · see citing works
Watanabe, M., Hirano, A., Stenglein, S., Nelson, J. A., Thomas, G., & Wong, T. C. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.3206-3210.1995 · Cited by 110 · see citing works
Co-option of an endogenous retrovirus envelope for host defense in hominid ancestors
Blanco-Melo, D., Gifford, R. J., & Bieniasz, P. D. (2017) · eLife · doi:10.7554/elife.22519 · Cited by 109 · see citing works
Walker, J. A., Molloy, S. S., Thomas, G., Sakaguchi, T., Yoshida, T., Chambers, T. M., & Kawaoka, Y. (1994) · Journal of Virology · doi:10.1128/jvi.68.2.1213-1218.1994 · Cited by 108 · see citing works
Envelope Glycoprotein of Arenaviruses
Burri, D. J., da Palma, J. R., Kunz, S., & Pasquato, A. (2012) · Viruses · doi:10.3390/v4102162 · Cited by 108 · see citing works
Creemers, J. W. M., Vey, M., Schäfer, W., Ayoubi, T., Roebroek, A., Klenk, H., Garten, W., & de Ven, W. J. M. V. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2695 · Cited by 108 · see citing works
Self-citationGnirß, K., Krämer-Kühl, A., Karsten, C. B., Glowacka, I., Bertram, S., Kaup, F. ‐., Hofmann, H., & Pöhlmann, S. (2012) · Virology · doi:10.1016/j.virol.2011.11.031 · Cited by 108 · see citing works
Barale, J.-C., Blisnick, T., Fujioka, H., Alzari, P. M., Aikawa, M., Braun‐Breton, C., & Langsley, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6445 · Cited by 107 · see citing works
Mechanism of Borna Disease Virus Entry into Cells
Gonzalez‐Dunia, D., Cubitt, B., & de la Torre, J. C. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.783-788.1998 · Cited by 106 · see citing works
Basak, A., Zhong, M., Munzer, J. S., Chrétien, M., & Seidah, N. G. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530537 · Cited by 105 · see citing works
Processing of proendothelin‐1 by human furin convertase
Denault, J., Claing, A., D’Orléans-Juste, P., Sawamura, T., Kido, T., Masaki, Τ., & Leduc, R. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00249-9 · Cited by 104 · see citing works
Priming Time: How Cellular Proteases Arm Coronavirus Spike Proteins
Hoffmann, M., Hofmann-Winkler, H., & Pöhlmann, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-75474-1_4 · Cited by 101 · see citing works
Recent strategies targeting HIV glycans in vaccine design
Horiya, S., MacPherson, I. S., & Krauss, I. J. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1685 · Cited by 102 · see citing works
Spies, C. P., Ritter, G., Mulligan, M. J., & Compans, R. W. (1994) · Journal of Virology · doi:10.1128/jvi.68.2.585-591.1994 · Cited by 102 · see citing works
Yang, C., Spies, C. P., & Compans, R. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9871 · Cited by 100 · see citing works
Structural analysis of SARS-CoV-2 genome and predictions of the human interactome
Vandelli, A., Monti, M. M., Milanetti, E., Armaos, A., Rupert, J., Zacco, E., Bechara, E., Ponti, R. D., & Tartaglia, G. G. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa864 · Cited by 99 · see citing works
Okumura, Y., Takahashi, E., Yano, M., Ohuchi, M., Daidoji, T., Nakaya, T., Böttcher, E., Garten, W., Klenk, H., & Kido, H. (2010) · Journal of Virology · doi:10.1128/jvi.02605-09 · Cited by 97 · see citing works
Self-citationHomology modelling of the catalytic domain of human furin
Siezen, R. J., Creemers, J. W. M., & de Ven, W. J. M. V. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18864.x · Cited by 97 · see citing works
Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches
Gioia, M., Ciaccio, C., Calligari, P. A., Simone, G. D., Sbardella, D., Tundo, G. R., Fasciglione, G. F., di Masi, A., Pierro, D. D., Bocedi, A., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114225 · Cited by 97 · see citing works
- Authors
- Hallenberger, S., Bosch, V., Angliker, H., Shaw, E., Klenk, H.-D., & Garten, W.
- Affiliations
- Philipps University of Marburg (DE)
- German Cancer Research Center (DE)
- Friedrich Miescher Institute (CH)
- Venue
- Nature
- Published
- 1992-11-26
- Volume
- 360
- Issue
- 6402
- Pages
- 358-361
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2001675486
- Cited by
- 582
- References
- 23
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 14 · 2023: 18 · 2022: 13 · 2021: 24 · 2020: 23 · 2019: 14 · 2018: 20 · 2017: 9 · 2016: 14 · 2015: 23 · 2014: 24 · 2013: 17 · 2012: 27
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- furin, HIV-1 envelope glycoprotein, gp160, proteolytic cleavage, furin inhibitors, viral fusion, infectious virus particles, endopeptidase
- MeSH terms
- Amino Acid Chloromethyl Ketones, Amino Acid Sequence, HeLa Cells, Humans, Molecular Sequence Data, Protein Precursors, Substrate Specificity, Subtilisins, Virus Replication, CD4-Positive T-Lymphocytes, HIV-1, Gene Products, env, Gene Expression, Consensus Sequence, HIV Envelope Protein gp160, Furin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review